Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1207062

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1207062

Stem Cell Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

PUBLISHED:
PAGES: 127 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2499
PDF & Excel (5 User License)
USD 3499
PDF & Excel (Corporate License)
USD 4499

Add to Cart

The global stem cell manufacturing market size reached US$ 12.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.

Stem cells are undifferentiated or partially differentiated cells that make up the tissues and organs of animals and plants. They are commonly sourced from blood, bone marrow, umbilical cord, embryo, and placenta. Under the right body and laboratory conditions, stem cells can divide to form more cells, such as red blood cells (RBCs), platelets, and white blood cells, which generate specialized functions. They are widely used for human disease modeling, drug discovery, development of cell therapies for untreatable diseases, gene therapy, and tissue engineering. Stem cells are cryopreserved to maintain their viability and minimize genetic change and are consequently used later to replace damaged organs and tissues and treat various diseases.

Stem Cell Manufacturing Market Trends:

  • The global market is primarily driven by the increasing venture capital (VC) investments in stem cell research due to the rising awareness about the therapeutic potency of stem cells. Apart from this, the widespread product utilization in effective disease management, personalized medicine, and genome testing applications are favoring the market growth. Additionally, the incorporation of three-dimensional (3D) printing and microfluidic technologies to reduce production time and lower cost by integrating multiple production steps into one device is providing an impetus to the market growth. Furthermore, the increasing product utilization in the pharmaceutical industry for manufacturing hematopoietic stem cells (HSC)- and mesenchymal stem cells (MSC)-based drugs for treating tumors, leukemia, and lymphoma is acting as another growth-inducing factor. Moreover, the increasing product application in research applications to produce new drugs that assist in improving functions and altering the progress of diseases is providing a considerable boost to the market. Other factors, including the increasing usage of the technique in tissue and organ replacement therapies, significant improvements in medical infrastructure, and the implementation of various government initiatives promoting public health, are anticipated to drive the market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global stem cell manufacturing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

  • Consumables
  • Culture Media
  • Others
  • Instruments
  • Bioreactors and Incubators
  • Cell Sorters
  • Others
  • Stem Cell Lines
  • Hematopoietic Stem Cells (HSC)
  • Mesenchymal Stem Cells (MSC)
  • Induced Pluripotent Stem Cells (iPSC)
  • Embryonic Stem Cells (ESC)
  • Neural Stem Cells (NSC)
  • Multipotent Adult Progenitor Stem Cells

Breakup by Application:

  • Research Applications
  • Life Science Research
  • Drug Discovery and Development
  • Clinical Application
  • Allogenic Stem Cell Therapy
  • Autologous Stem Cell Therapy
  • Cell and Tissue Banking Applications

Breakup by End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes, Research Laboratories and Contract Research Organizations
  • Hospitals and Surgical Centers
  • Cell and Tissue banks
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Anterogen Co. Ltd., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Corning Incorporated, FUJIFILM Holdings Corporation, Lonza Group AG, Merck KGaA, Sartorius AG, Takara Bio Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • 1. What was the size of the global stem cell manufacturing market in 2022?
  • 2. What is the expected growth rate of the global stem cell manufacturing market during 2023-2028?
  • 3. What are the key factors driving the global stem cell manufacturing market?
  • 4. What has been the impact of COVID-19 on the global stem cell manufacturing market?
  • 5. What is the breakup of the global stem cell manufacturing market based on product?
  • 6. What is the breakup of the global stem cell manufacturing market based on the application?
  • 7. What is the breakup of the global stem cell manufacturing market based on the end user?
  • 8. What are the key regions in the global stem cell manufacturing market?
  • 9. Who are the key players/companies in the global stem cell manufacturing market?
Product Code: SR1323A534_Report

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Stem Cell Manufacturing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Culture Media
      • 6.1.2.2 Others
    • 6.1.3 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Bioreactors and Incubators
      • 6.2.2.2 Cell Sorters
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Stem Cell Lines
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Hematopoietic Stem Cells (HSC)
      • 6.3.2.2 Mesenchymal Stem Cells (MSC)
      • 6.3.2.3 Induced Pluripotent Stem Cells (iPSC)
      • 6.3.2.4 Embryonic Stem Cells (ESC)
      • 6.3.2.5 Neural Stem Cells (NSC)
      • 6.3.2.6 Multipotent Adult Progenitor Stem Cells
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Research Applications
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Life Science Research
      • 7.1.2.2 Drug Discovery and Development
    • 7.1.3 Market Forecast
  • 7.2 Clinical Application
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Allogenic Stem Cell Therapy
      • 7.2.2.2 Autologous Stem Cell Therapy
    • 7.2.3 Market Forecast
  • 7.3 Cell and Tissue Banking Applications
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical & Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Academic Institutes, Research Laboratories and Contract Research Organizations
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hospitals and Surgical Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cell and Tissue banks
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Anterogen Co. Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bio-Rad Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Techne Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Corning Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 FUJIFILM Holdings Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Lonza Group AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Sartorius AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Takara Bio Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
Product Code: SR1323A534_Report

List of Figures

  • Figure 1: Global: Stem Cell Manufacturing Market: Major Drivers and Challenges
  • Figure 2: Global: Stem Cell Manufacturing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Stem Cell Manufacturing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Stem Cell Manufacturing Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Stem Cell Manufacturing Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Stem Cell Manufacturing Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Stem Cell Manufacturing Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Stem Cell Manufacturing (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Stem Cell Manufacturing (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Stem Cell Manufacturing (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Stem Cell Manufacturing (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Stem Cell Manufacturing (Stem Cell Lines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Stem Cell Manufacturing (Stem Cell Lines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Stem Cell Manufacturing (Research Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Stem Cell Manufacturing (Research Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Stem Cell Manufacturing (Clinical Application) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Stem Cell Manufacturing (Clinical Application) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Stem Cell Manufacturing (Cell and Tissue Banking Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Stem Cell Manufacturing (Cell and Tissue Banking Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Stem Cell Manufacturing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Stem Cell Manufacturing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Stem Cell Manufacturing (Academic Institutes, Research Laboratories and Contract Research Organizations) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Stem Cell Manufacturing (Academic Institutes, Research Laboratories and Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Stem Cell Manufacturing (Hospitals and Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Stem Cell Manufacturing (Hospitals and Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Stem Cell Manufacturing (Cell and Tissue banks) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Stem Cell Manufacturing (Cell and Tissue banks) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Stem Cell Manufacturing (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Stem Cell Manufacturing (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Stem Cell Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Stem Cell Manufacturing Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Stem Cell Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Stem Cell Manufacturing Industry: SWOT Analysis
  • Figure 80: Global: Stem Cell Manufacturing Industry: Value Chain Analysis
  • Figure 81: Global: Stem Cell Manufacturing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Stem Cell Manufacturing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Stem Cell Manufacturing Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Stem Cell Manufacturing Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Stem Cell Manufacturing Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Stem Cell Manufacturing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Stem Cell Manufacturing Market: Competitive Structure
  • Table 7: Global: Stem Cell Manufacturing Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!